Alvotech And Teva File US Stelara Rival Ahead Of 2023 Expiry

Filing For AVT04 Proposed Ustekinumab Biosimilar Is Accepted By US FDA

 
• By David Wallace
  
Sign outside of FDA's headquarters in White Oak, MD
Alvotech’s Stelara biosimilar has been filed with the FDA • Source: Alamy

More from Biosimilars

More from Products